She plans to collaborate with researchers from the University’s College of Agriculture, Biotechnology & Natural Resources and ...

The Cas nuclease market is on an upward trajectory, forecasted to grow from $2.75 billion in 2023 to $3.27 billion in 2024, at a CAGR of 18.9%. Key drivers include the rapid advancements in genome ...

Institutional investors and hedge funds own 1.70% of the company’s stock. Origin Agritech Limited, together with its subsidiaries, operates as an agricultural biotechnology in the People’s Republic of ...

DALLAS (AP) — DALLAS (AP) — Arcadia Biosciences Inc. (RKDA) on Tuesday reported a loss of $1.6 million in its third quarter. On a per-share basis, the Dallas-based company said it had a loss of $1.18.

Austin Moeller, an analyst from Canaccord Genuity, maintained the Buy rating on Cibus (CBUS – Research Report). The associated price ...

Arcadia Biosciences (RKDA) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $1.83 per share a year ago. These figures ...

The Vignan University is advancing with the noble objectives of creating top-notch job opportunities for the youth, ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

A new study has made significant strides in plant genome editing by developing an A-to-K base editing system for rice and ...

A group of investors in Locus Solutions, a biotechnology company headquartered in Solon ... is an agtech business that has ...

If the United States does not lead in emerging biotechnologies, our adversaries will, writes GOP Sen. Todd Young of Indiana.

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...